As of Oct 20
| -0.06 / -0.12%|
The 24 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 53.39, with a high estimate of 59.77 and a low estimate of 39.96. The median estimate represents a +9.21% increase from the last price of 48.89.
The current consensus among 27 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.